What is squamous cell carcinoma
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest squamous cell carcinoma (SCC) is a common, aggressive cancer that can occur in various body sites, with treatment and outcomes improved by new therapies, prevention measures, and targeted approaches based on genetic abnormalities.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding Squamous Cell Carcinoma (SCC)
Introduction to Squamous Cell Carcinoma
Squamous Cell Carcinoma (SCC) is a type of cancer that originates from squamous cells, which are flat cells found in the outer layer of the skin and various mucous membranes. SCC is characterized by the abnormal growth of these cells, leading to the formation of malignant tumors. It is one of the most common types of skin cancer and can also occur in other parts of the body, including the lungs, head, neck, and larynx .
Cutaneous Squamous Cell Carcinoma (cSCC)
Cutaneous Squamous Cell Carcinoma (cSCC) is a subtype of SCC that affects the skin. It is the second most common form of non-melanoma skin cancer, following basal cell carcinoma. cSCC can present as in situ (localized) or invasive forms, with the potential to metastasize and cause significant morbidity and mortality . Key risk factors for cSCC include prolonged sun exposure, fair skin, advanced age, immunosuppression, and a history of previous skin cancers .
Pathogenesis and Risk Factors
The development of cSCC is a multistage process involving genetic mutations, epigenetic changes, and environmental factors. Mutations in genes responsible for epidermal homeostasis, such as p53 and epidermal growth factor receptor (EGFR), play a crucial role in the progression from actinic keratosis (a precursor lesion) to invasive cSCC . Chronic sun exposure is a significant risk factor, contributing to DNA damage and subsequent carcinogenesis .
Diagnosis and Treatment
Diagnosis of cSCC typically involves clinical examination, dermoscopy, and biopsy for histopathological confirmation. Reflectance confocal microscopy can enhance diagnostic accuracy. Treatment options include surgical excision, Mohs micrographic surgery, radiotherapy, and systemic therapies such as immunotherapy with immune checkpoint inhibitors (e.g., Cemiplimab) and EGFR inhibitors for advanced cases .
Squamous Cell Carcinoma of the Lung (SQCLC)
Squamous Cell Carcinoma of the Lung (SQCLC) is a subtype of non-small-cell lung cancer characterized by unique molecular and clinicopathological features. Historically, it was the most common subtype of lung cancer but has been surpassed by adenocarcinoma in recent years. Key molecular alterations in SQCLC include SOX2 amplification, NFE2L2 and KEAP1 mutations, and changes in the PI3K pathway, which have led to the development of targeted therapies.
Clinical Characteristics and Treatment
SQCLC typically presents as central tumors with high molecular complexity. Treatment approaches have evolved with the advent of targeted therapies, which have shown promise in improving outcomes for patients with specific genetic alterations.
Head and Neck Squamous Cell Carcinoma (HNSCC)
Head and Neck Squamous Cell Carcinoma (HNSCC) encompasses cancers arising from the oral cavity, oropharynx, hypopharynx, and larynx. Risk factors include tobacco use, alcohol consumption, and infection with oncogenic viruses such as human papillomavirus (HPV) . HNSCC is characterized by genetic alterations in tumor suppressor genes and proto-oncogenes, leading to invasive malignancy.
Diagnosis and Management
Early-stage HNSCC is typically treated with single-modality therapy (surgery or radiotherapy), while advanced stages require multimodal treatment, including surgery, chemoradiation, and targeted therapies. The increasing incidence of HPV-associated oropharyngeal cancer has influenced treatment strategies and prognosis.
Conclusion
Squamous Cell Carcinoma (SCC) is a diverse group of cancers arising from squamous cells in various tissues. Cutaneous SCC, lung SCC, and head and neck SCC each have distinct risk factors, molecular characteristics, and treatment approaches. Advances in understanding the molecular biology of SCC have led to the development of targeted therapies, improving patient outcomes. Early diagnosis and appropriate management are crucial for effective treatment and reducing the risk of recurrence and metastasis.
Sources and full results
Most relevant research papers on this topic
